Streetbeat News

Stock Prices

CRDF

Cardiff Oncology, Inc. (NASDAQ:CRDF) has announced positive clinical data from its ongoing trials of onvansertib monotherapy and combination therapy in metastatic pancreatic ductal adenocarcinoma (mPDAC) and small cell lung cancer (SCLC). The company also plans to initiate a first-line trial for mPDAC. The data from the trials show promising results, with the pancreatic cancer Phase 2 trial showing greater efficacy compared to historical controls. The company will hold a conference call to discuss the preliminary data.

Portfolio Pulse from Happy Mohamed

September 26, 2023 | 8:09 pm

ADVM

Adverum Biotechnologies has reported Aflibercept protein level data from its LUNA Phase 2 trial. The company states that Ixo-vec has been well tolerated with a favorable preliminary safety profile.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2023 | 8:07 pm

MLKN

MillerKnoll (NASDAQ:MLKN) reported Q1 earnings of $0.37 per share, beating the analyst consensus estimate of $0.21 by 76.19%. However, this is a 15.91% decrease from the same period last year. The company also reported quarterly sales of $917.70 million, beating the estimate of $899.60 million by 2.01%, but marking a 14.95% decrease from last year.

Portfolio Pulse from Happy Mohamed

September 26, 2023 | 8:06 pm

AMT

A significant amount of unusual options activity has been detected for American Tower (NYSE:AMT), with a majority of investors taking a bearish stance. The price range targeted by these investors is between $150.0 and $180.0. The current price of AMT is $163.49, down by 1.35%. Morgan Stanley has maintained their Equal-Weight rating on American Tower, with a price target of $212.

Portfolio Pulse from Benzinga Insights

September 26, 2023 | 8:01 pm

COP

A significant amount of unusual options activity has been observed for ConocoPhillips (NYSE:COP), with a bearish stance being taken by a whale investor. Of the 22 strange trades detected, 45% were bullish and 54% were bearish. The total amount for puts was $383,464 and for calls was $827,317. Whales have been targeting a price range from $30.0 to $130.0 for ConocoPhillips over the last 3 months. The current price of COP is down -0.82% at $120.08.

Portfolio Pulse from Benzinga Insights

September 26, 2023 | 8:01 pm

MLI

Mueller Industries, Inc. has announced a two-for-one stock split in the form of a 100% stock dividend. The distribution date is set for October 20.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2023 | 8:01 pm

PLTR

A significant investor has taken a bearish stance on Palantir Technologies (NYSE:PLTR), with 60% of recent trades being bearish. The targeted price range for Palantir over the last 3 months is between $10.0 and $25.0. The current price of PLTR is down 2.0% at $13.94. HSBC, Wedbush, and Morgan Stanley have downgraded their actions on Palantir with price targets of $16, $25, and $9 respectively.

Portfolio Pulse from Benzinga Insights

September 26, 2023 | 8:01 pm

PAYX

Analysts have provided mixed ratings for Paychex (NASDAQ:PAYX) in the last quarter, with 1 somewhat bullish, 5 indifferent, and 3 somewhat bearish. The average price target is $122.78, indicating potential upside from the current price of $112.58. This average has increased by 0.75% from the previous target of $121.86.

Portfolio Pulse from Benzinga Insights

September 26, 2023 | 8:00 pm

AMD

Advanced Micro Devices, Inc. (AMD) shares fell by 2.0% amid overall market weakness due to concerns about future rate hikes and lower-than-expected initial jobless claims data. AMD's profitability and valuation could be affected by rising interest rates as it relies on borrowing for research and development and capital investments. Higher interest rates could also reduce consumer spending on technology products, negatively impacting AMD's sales and earnings.

Portfolio Pulse from Henry Khederian

September 26, 2023 | 7:53 pm

AAPL

Apple Inc's shares are trading lower by 2.5% amid concerns about future rate hikes and lower-than-expected initial jobless claims data. Higher interest rates could increase the cost of borrowing for consumers, potentially reducing the affordability of Apple products and leading to lower sales and revenue. Additionally, rising interest rates could make it more expensive for Apple to finance debt, leading to higher interest expenses and reducing its net income.

Portfolio Pulse from Henry Khederian

September 26, 2023 | 7:51 pm